序号 |
标题 |
次数 |
作者 |
发布时间 |
84736 |
DOTA octreotide,大环配体奥曲肽 |
101 |
zyl |
2024-11-27 |
84737 |
3,6-二胍基-1,2,4,5-四嗪(DGTZ) |
104 |
WYQ |
2024-11-27 |
84738 |
gallium Ga 68-DOTATATE , 镓68偶联DOTATATE螯合物 |
173 |
kx |
2024-11-27 |
84739 |
3,6-二叠氮基-1,2,4,5-四嗪(DIAT) |
104 |
WYQ |
2024-11-27 |
84740 |
DOTA N-hydroxysulfosuccinimide ester 170908-81-3 DOTA-活性酯 |
95 |
zcy |
2024-11-27 |
84741 |
四嗪类高氮含能化合物 |
216 |
WYQ |
2024-11-27 |
84742 |
p-SCN-Bn-DOTA , 2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
94 |
kx |
2024-11-27 |
84743 |
咪唑并四嗪(Imidazopyrazine) |
98 |
WYQ |
2024-11-27 |
84744 |
二聚体多肽,250612-06-7 |
106 |
zyl |
2024-11-27 |
84745 |
DOTA-(t-Butyl)3-PEG5-azide 点击化学试剂 |
105 |
zcy |
2024-11-27 |
84746 |
降冰片烯衍生物(C16-NCA) |
188 |
WYQ |
2024-11-27 |
84747 |
DOTA-CS微球 ,壳聚糖微球上接枝螯合剂1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA) |
86 |
kx |
2024-11-27 |
84748 |
1, 4, 7,10-四氮杂环十二烷-1, 4, 7-三(乙酸)-10-(2-硫乙基)乙酰胺 |
88 |
zcy |
2024-11-27 |
84749 |
3,6-二肼基-1,2,4,5-四嗪(DHT) |
121 |
WYQ |
2024-11-27 |
84750 |
DBCO-SS-PEG-DOTA 二苯并环辛炔-聚乙二醇之四氮杂环十二烷 |
91 |
zyl |
2024-11-27 |
84751 |
3-叠氮基-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(IADMPT) |
107 |
WYQ |
2024-11-27 |
84752 |
3-肼基-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(HDMP |
113 |
WYQ |
2024-11-27 |
84753 |
p-NH2-Bn-DOTA(B-200);181065-46-3;基于NOTADOTA定制和偶联 |
82 |
zcy |
2024-11-27 |
84754 |
DOTA-CSar-1 ,DOTA-胆酰肌氨酸 |
144 |
kx |
2024-11-27 |
84755 |
DOTA-MeTz,1610950-41-8,DOTA-甲基四嗪 |
96 |
zyl |
2024-11-27 |
84756 |
四嗪Tetrazine (C18-Tz) |
260 |
WYQ |
2024-11-27 |
84757 |
3-硝铵基-6-(1H-四唑-5-基)-[1,2,4]三唑[4,3-b][1,2,4,5]四嗪羟胺盐(TATTN·NH3OH) |
123 |
WYQ |
2024-11-27 |
84758 |
3-硝铵基-6-(1H-四唑-5-基)-[1,2,4]三唑[4,3-b][1,2,4,5]四嗪铵盐(TATTN·NH4) |
110 |
WYQ |
2024-11-27 |
84759 |
HA-ASP-CYS-Gd-DOTA ,透明质酸为载体的靶向肿瘤的大分子T1钆基造影剂 |
126 |
kx |
2024-11-27 |
84760 |
CAS:3001301-68-1;DOTA(单酰胺)-OH;DOTA(Monoamides)-OH |
95 |
zcy |
2024-11-27 |
84761 |
DOTA NOC acetate,619300-53-7 |
125 |
zyl |
2024-11-27 |
84762 |
DOTA-SC691-6KL,DOTA偶联卤素取代物 |
106 |
kx |
2024-11-27 |
84763 |
不对称炔丙基取代(+)-Citralis-Propargyl |
100 |
WYQ |
2024-11-27 |
84764 |
不对称炔丙基取代(+)-Phenoxanol-Propargyl |
71 |
WYQ |
2024-11-27 |
84765 |
CAS:250612-06-7;DOTA-RGD探针二聚体;dota-glu[cyclo(arg-gly-asp-d-phe-lys)]2 |
85 |
zcy |
2024-11-27 |
84766 |
不对称炔丙基取代(-)-AMG 837 |
85 |
WYQ |
2024-11-27 |
84767 |
PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针 |
84 |
kx |
2024-11-27 |
84768 |
不对称炔丙基取代(+)-Phenoxanol-Propargyl |
76 |
WYQ |
2024-11-27 |
84769 |
2125661-62-1;Butyne-DOTA;白色固体 |
77 |
zcy |
2024-11-27 |
84770 |
不对称炔丙基取代(-)-AMG 837 |
128 |
WYQ |
2024-11-27 |
84771 |
DOTA-t-Bu ester , 1-(乙氧羰甲基)-4,7,10-三(叔丁氧羰甲基)-1,4,7,10-四氮杂环十二烷 |
107 |
kx |
2024-11-27 |
84772 |
螯合剂多肽,cyclo(RGDFK(DOTA)) |
171 |
zyl |
2024-11-27 |
84773 |
DOTA-Ala-Ala-COOH |
84 |
zyl |
2024-11-27 |
84774 |
3-硝铵基-6-(1H-四唑-5-基)-[1,2,4]三唑[4,3-b][1,2,4,5]四嗪肼盐(TATTN·N2H4) 1. 基本信息 |
97 |
WYQ |
2024-11-27 |
84775 |
DOTA-EB-TMTP , 双功能螯合剂DOTA修饰多肽TMTP1 ,DOTA-EB-NVVRQ |
140 |
kx |
2024-11-27 |
84776 |
3-硝铵基-6-(1H-四唑-5-基)-[1,2,4]三唑[4,3-b][1,2,4,5]四嗪(TATTN) 1. 基本信息 |
109 |
WYQ |
2024-11-27 |
84777 |
PSMA IandT,DOTA-多肽分子探针 |
123 |
zyl |
2024-11-27 |
84778 |
不对称炔丙基取代柠檬腈 (-)-Citralis Nitrile-Propargyl |
172 |
WYQ |
2024-11-27 |
84779 |
聚乙二醇与壳聚糖接枝抗菌肽大分子偶联物(CS-PEG-WW11) |
189 |
WYQ |
2024-11-27 |
84780 |
DOTA-NAPA mide , DOTA偶联α-MSH类似物 |
95 |
kx |
2024-11-27 |